At the news
? NEUTRALIMPACT 2/10 144 filed Nov 10, 2026 at 12:45 ET
Judith V. Klimovsky, an officer of Genmab, filed a Form 144 notice of intent to sell 1,265 shares of common stock, with an estimated aggregate market value of approximately $704,327. The shares were acquired through stock awards in 2021 and 2023. The sale is relatively small relative to the company's $33.5B market cap and appears to be a routine insider transaction.
- Insider Judith V. Klimovsky (Officer) filed Form 144 to sell 1,265 shares of Genmab common stock.
- Estimated aggregate market value of the proposed sale is approximately $704,327.
- Shares were acquired via stock awards on 01/06/2021 (365 shares) and 01/02/2023 (900 shares) as compensation.
- The sale is planned for or around 11/10/2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access